10.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GLUE Giù?
Forum
Previsione
Monte Rosa Therapeutics Inc Borsa (GLUE) Ultime notizie
Advanced analytics toolkit walkthrough for Monte Rosa Therapeutics Inc.Earnings Recap Summary & Real-Time Volume Triggers - newser.com
Why Monte Rosa Therapeutics Inc. stock could benefit from AI revolutionWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Monte Rosa Therapeutics, Inc. Experiences Valuation Adjustment Amid Strong Market Performance - Markets Mojo
Day 6 of Gains Streak for Monte Rosa Therapeutics Stock with 51% Return (vs. 60% YTD) [10/15/2025] - Trefis
Monte Rosa's Stock Gains on Signing $5.7B Licensing Deal With Novartis - MSN
Custom watchlist performance reports with Monte Rosa Therapeutics Inc.July 2025 Market Mood & Safe Entry Point Alerts - newser.com
Using economic indicators to assess Monte Rosa Therapeutics Inc. potentialMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Applying sector rotation models to Monte Rosa Therapeutics Inc.2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
Why Monte Rosa Therapeutics Inc. stock is popular among millennials2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Using data models to predict Monte Rosa Therapeutics Inc. stock movementEarnings Beat & High Accuracy Buy Signal Tips - newser.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Trading Up 7.9%Here's Why - MarketBeat
Monte Rosa Therapeutics Inc. stock momentum explainedWeekly Gains Summary & Verified Entry Point Signals - newser.com
What analysts say about Monte Rosa Therapeutics Inc stockValue Traps to Avoid & Outstanding Growth Strategies - earlytimes.in
Does Monte Rosa Therapeutics Inc. fit your quant trading modelJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com
Monte Rosa Therapeutics Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
Signal strength of Monte Rosa Therapeutics Inc. stock in tech scannersDollar Strength & Low Drawdown Momentum Trade Ideas - newser.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Earns "Sell (D)" Rating from Weiss Ratings - MarketBeat
Will Monte Rosa Therapeutics Inc. see short term momentum2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Comparing Monte Rosa Therapeutics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
How high can Monte Rosa Therapeutics Inc. stock goShort Setup & Advanced Technical Analysis Signals - newser.com
Dimension Capital Group Discloses 4.76M Shares (7.7%) in GLUE - Stock Titan
Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects - MSN
11 Best Fast Money Stocks to Buy Now - Insider Monkey
Is Monte Rosa Therapeutics Inc a good long term investmentGeopolitical Risk Analysis & Consistent Double Returns - earlytimes.in
Monte Rosa Therapeutics Inc Stock Analysis and ForecastLarge Cap Stability Picks & Fast Profit Trading Ideas - earlytimes.in
Full technical analysis of Monte Rosa Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - newser.com
Is Monte Rosa Therapeutics Inc. stock reversal real or fakeWatch List & Daily Chart Pattern Signals - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):